210 related articles for article (PubMed ID: 7814636)
21. Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.
Bork K; Gül D; Hardt J; Dewald G
Am J Med; 2007 Nov; 120(11):987-92. PubMed ID: 17976427
[TBL] [Abstract][Full Text] [Related]
22. Hereditary angioedema with a de novo mutation of exon 8 in the C1 inhibitor gene showing recurrent edema of the hands around the peripheral joints: importance for the differential diagnosis of joint swelling.
Sugiyama E; Ozawa T; Taki H; Maruyama M; Yamashita N; Ohta M; Hirata M; Kobayashi M
Arthritis Rheum; 2001 Apr; 44(4):974-7. PubMed ID: 11315937
[TBL] [Abstract][Full Text] [Related]
23. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
24. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
Aulak KS; Davis AE; Donaldson VH; Harrison RA
Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
[TBL] [Abstract][Full Text] [Related]
25. A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu).
Frangi D; Aulak KS; Cicardi M; Harrison RA; Davis AE
FEBS Lett; 1992 Apr; 301(1):34-6. PubMed ID: 1451784
[TBL] [Abstract][Full Text] [Related]
26. HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene.
Kalmár L; Hegedüs T; Farkas H; Nagy M; Tordai A
Hum Mutat; 2005 Jan; 25(1):1-5. PubMed ID: 15580551
[TBL] [Abstract][Full Text] [Related]
27. Three-dimensional structure and molecular modelling of C1- inhibitor.
Perkins SJ
Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
[TBL] [Abstract][Full Text] [Related]
28. Hereditary angioedema caused by a point mutation of exon 7 in the C1 inhibitor gene.
Ishii N; Ono H; Kawaguchi H; Nakajima H
Br J Dermatol; 1996 Apr; 134(4):731-3. PubMed ID: 8733381
[TBL] [Abstract][Full Text] [Related]
29. Altered C1 inhibitor genes in type I hereditary angioedema.
Stoppa-Lyonnet D; Tosi M; Laurent J; Sobel A; Lagrue G; Meo T
N Engl J Med; 1987 Jul; 317(1):1-6. PubMed ID: 3587308
[TBL] [Abstract][Full Text] [Related]
30. Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases.
Zahedi R; Wisnieski J; Davis AE
J Immunol; 1997 Jul; 159(2):983-8. PubMed ID: 9218620
[TBL] [Abstract][Full Text] [Related]
31. Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema.
Kalmár L; Bors A; Farkas H; Vas S; Fandl B; Varga L; Füst G; Tordai A
Hum Mutat; 2003 Dec; 22(6):498. PubMed ID: 14635117
[TBL] [Abstract][Full Text] [Related]
32. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
[TBL] [Abstract][Full Text] [Related]
33. Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.
Zahedi R; Bissler JJ; Davis AE; Andreadis C; Wisnieski JJ
J Clin Invest; 1995 Mar; 95(3):1299-305. PubMed ID: 7883978
[TBL] [Abstract][Full Text] [Related]
34. A point mutation in exon 7 of the C1-inhibitor gene causing type I hereditary angioedema.
Ono H; Kawaguchi H; Ishii N; Nakajima H
Hum Genet; 1996 Oct; 98(4):452-3. PubMed ID: 8792821
[TBL] [Abstract][Full Text] [Related]
35. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
[TBL] [Abstract][Full Text] [Related]
36. Molecular cloning of the cDNA coding for human C1 inhibitor.
Rauth G; Schumacher G; Buckel P; Müller-Esterl W
Protein Seq Data Anal; 1988; 1(4):251-7. PubMed ID: 3393514
[TBL] [Abstract][Full Text] [Related]
37. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
38. Expression of active human C1 inhibitor serpin domain in Escherichia coli.
Lamark T; Ingebrigtsen M; Bjørnstad C; Melkko T; Mollnes TE; Nielsen EW
Protein Expr Purif; 2001 Jul; 22(2):349-58. PubMed ID: 11437612
[TBL] [Abstract][Full Text] [Related]
39. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.
Verpy E; Biasotto M; Brai M; Misiano G; Meo T; Tosi M
Am J Hum Genet; 1996 Aug; 59(2):308-19. PubMed ID: 8755917
[TBL] [Abstract][Full Text] [Related]
40. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
